Truffle Capital is a venture capital and private equity firm investing in technology companies that is headquartered in Paris, France and was founded in 2001 by Bernard-Louis Roques, Henri Moulard, Jean-Francois Fourt, and Philippe Pouletty. According to the firms website 9 (as of December 2019), Truffle Capital has €500 under management, has made 75 investments since its founding, and has 24 employees.
A synthetic biology company making antibiotics and bioactives.
Altimmune is a therapeutics, treatment, and vaccine development company that looks to find response and prevention solutions
Actility is a software company providing low power wide area (LoRaWAN and 3GPP connectivity) network connectivity management.
Pharnext is a very well advanced clinical-stage biopharmaceutical company
CARBIOS is a Saint-Beauzire, Haute-Loire-based company.
Theradiag is a France-based medical diagnostics company developing tracker kits and biotherapy monitoring kits.